This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bergström, G. Articles by Anderson, W. P. Search for Related Content PubMed PubMed Citation Articles by Bergström, G. Articles by Anderson, W. P.

(Hypertension. 1998;31:1007-1013.)
© 1998 American Heart Association, Inc.

Scientific Contributions

Perindopril Treatment Affects Both Preglomerular Renal Vascular Lumen Dimensions and In Vivo Responsiveness to Vasoconstrictors in Spontaneously Hypertensive Rats

Göran Bergström; Inger Johansson; Kathleen M. Stevenson; Michelle M. Kett; ; Warwick P. Anderson

From the Department of Physiology, Monash University, Clayton, Victoria, Australia.

Abstract—We have previously shown that chronic treatment with angiotensin-converting enzyme inhibition (ACEI) did not reverse hypertrophy of the renal arterial wall in spontaneously hypertensive rats (SHR). In this study we determined the effects of perindopril on the functional properties of the renal vasculature in vivo and on its resistance to flow at maximal dilatation in vitro, a measure of vessel lumen diameter. Two groups of SHR were studied: untreated or treated with perindopril (3 mg/kg per day) in their drinking water from 4 weeks of age. At 10 weeks, (1) vessel lumen characteristics were assessed using a maximally dilated in vitro isolated kidney perfusion and (2) the renal vasoconstrictor responses to bolus doses of vasoactive agents (angiotensin II and phenylephrine) administered into the renal artery were measured in vivo (anesthetized rats). Mean arterial pressure was significantly lower in conscious SHR treated with perindopril (132±2 versus 97±2 mm Hg, P<.001). In vitro, the pressure-flow relationship and the pressure–glomerular filtration rate relationship were both shifted significantly to the left (P<.001). The perindopril-treated kidneys began filtering at a significantly lower threshold perfusion pressure than nontreated controls (P<.001). In vivo, renal vasoconstrictor responses to increasing doses of both vasoconstrictor agents were significantly less marked in the perindopril-treated SHR than in untreated SHR (P<.05). Thus, chronic ACEI increased average renal vessel lumen diameter in SHR, predominantly in preglomerular vessels, and reduced renal vasoconstrictor responsiveness in vivo, findings compatible with remodeling of the preglomerular vasculature around a greater lumen.

Key Words: : • angiotensin-converting enzyme inhibitors • kidney • perfusion • rats, inbred SHR • vascular resistance

This article has been cited by other articles:

				K. M. Moritz, M. Q. Mazzuca, A. L. Siebel, A. Mibus, D. Arena, M. Tare, J. A. Owens, and M. E. Wlodek Uteroplacental insufficiency causes a nephron deficit, modest renal insufficiency but no hypertension with ageing in female rats J. Physiol., June 1, 2009; 587(11): 2635 - 2646. [Abstract] [Full Text] [PDF]

				A. Shweta, L. A. Cullen-McEwen, M. M. Kett, R. G. Evans, K. M. Denton, S. M. Fitzgerald, W. P. Anderson, and J. F. Bertram Glomerular surface area is normalized in mice born with a nephron deficit: no role for AT1 receptors Am J Physiol Renal Physiol, March 1, 2009; 296(3): F583 - F589. [Abstract] [Full Text] [PDF]

				R. R. Singh, L. A. Cullen-McEwen, M. M. Kett, W.-M. Boon, J. Dowling, J. F. Bertram, and K. M. Moritz Prenatal corticosterone exposure results in altered AT1/AT2, nephron deficit and hypertension in the rat offspring J. Physiol., March 1, 2007; 579(2): 503 - 513. [Abstract] [Full Text] [PDF]

				R. J. Johnson, J. Herrera-Acosta, G. F. Schreiner, and B. Rodriguez-Iturbe Subtle Acquired Renal Injury as a Mechanism of Salt-Sensitive Hypertension N. Engl. J. Med., March 21, 2002; 346(12): 913 - 923. [Full Text] [PDF]

				K. M. Stevenson, A. J. Edgley, G. Bergstrom, K. Worthy, M. M. Kett, and W. P. Anderson Angiotensin II Infused Intrarenally Causes Preglomerular Vascular Changes and Hypertension Hypertension, November 1, 2000; 36(5): 839 - 844. [Abstract] [Full Text] [PDF]

				W. P. Anderson, M. M. Kett, K. M. Stevenson, A. J. Edgley, K. M. Denton, and S. M. Fitzgerald Renovascular Hypertension : Structural Changes in the Renal Vasculature Hypertension, October 1, 2000; 36(4): 648 - 652. [Abstract] [Full Text] [PDF]

				F. Tomoda, M. Takata, H. Kinuno, S. Tomita, K. Yasumoto, and H. Inoue Renal Structural Properties in Prehypertensive Dahl Salt-Sensitive Rats Hypertension, July 1, 2000; 36(1): 68 - 72. [Abstract] [Full Text] [PDF]

				J. Zicha and J. Kunes Ontogenetic Aspects of Hypertension Development: Analysis in the Rat Physiol Rev, October 1, 1999; 79(4): 1227 - 1282. [Abstract] [Full Text] [PDF]

				B. Rodriguez-Iturbe, Y. Quiroz, M. Nava, L. Bonet, M. Chavez, J. Herrera-Acosta, R. J. Johnson, and H. A. Pons Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats Am J Physiol Renal Physiol, February 1, 2002; 282(2): F191 - F201. [Abstract] [Full Text] [PDF]